Gonorrhea cases up 17% in Europe

  • ECDC
  • ECDC

  • International Clinical Digest
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • European Centre for Disease Prevention and Control (ECDC) reports a 17% rise in gonorrhea cases from 2016 to 2017 across reporting European Union/European Economic Area (EU/EEA) countries.
  • Gonorrhea is now the second most notified sexually transmitted infection (STI) in the EU/EEA after chlamydia.

Why this matters

  • Consider pretravel consultations in high-risk patients (especially men who have sex with men [MSM], HIV-positive, and women of reproductive age).
  • Encourage condom use, increased testing uptake/frequency.

Key points

  • Report is based on gonorrhea case data collected by the European Sexually Transmitted Infection Surveillance Network, 2017.
  • 89,239 confirmed cases were reported by 27 EU/EEA member states in 2017, representing a 17% increase over 2016.
  • Crude notification rate: 22.2/100,000 population (22% increase vs 2016).
  • 17 countries accounted for 77% of cases, with highest rates (>25/100,000 population): UK (75/100,000), Ireland (47/100,000), Denmark (33/100,000), Iceland (29/100,000), Norway (27/100,000), Sweden (25/100,000).
  • MSM accounted, heterosexuals, unknown accounted for 47%, 45%, 9% of cases, respectively.
  • Largest increases since 2008 noted among ages 25-34 (2.7-fold), 35-44 (2.6-fold), ≥45 (2.6-fold) years.
  • 5-24 years accounted for 36% of 2017 cases.
  • Among cases with known HIV status, 14% were HIV-positive; 22% of known MSM HIV status cases were HIV-positive.

Please confirm your acceptance

To gain full access to GPnotebook please confirm:

By submitting here you confirm that you have accepted Terms of Use and Privacy Policy of GPnotebook.

Submit